Business Standard

Thursday, December 19, 2024 | 08:58 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

Saket Misra

Saket Misra

Saket Misra

Saket Misra

Excess vaccine-making capacity may get utilised in 3-5 years: Merck Life

Some 40-50 firms in India are getting into mRNA technology, says Aditya Sharma, senior executive of the German company

Excess vaccine-making capacity may get utilised in 3-5 years: Merck Life
Updated On : 18 Oct 2023 | 1:05 PM IST
Updated On : 16 Oct 2023 | 1:29 PM IST